HeartBeam (NASDAQ: BEAT)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of HeartBeam (NASDAQ: BEAT) through any online brokerage.
The latest price target for HeartBeam (NASDAQ: BEAT) was reported by Benchmark on Monday, December 20, 2021. The analyst firm set a price target for 9.00 expecting BEAT to rise to within 12 months (a possible 620.00% upside). 1 analyst firms have reported ratings in the last year.
The stock price for HeartBeam (NASDAQ: BEAT) is $1.25 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for HeartBeam.
HeartBeam’s Q2 earnings are confirmed for Friday, August 19, 2022.
There is no upcoming split for HeartBeam.
HeartBeam is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.